These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10817713)

  • 1. Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? The National Institute of Allergy and Infectious Diseases Mycoses study group.
    Goldman M; Cloud GA; Smedema M; LeMonte A; Connolly P; McKinsey DS; Kauffman CA; Moskovitz B; Wheat LJ
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1585-7. PubMed ID: 10817713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the fungitest kit by using strains from human immunodeficiency virus-infected patients: study of azole drug susceptibility.
    Witthuhn F; Toubas D; Béguinot I; Aubert D; Rouger C; Remy G; Pinon JM
    J Clin Microbiol; 1999 Mar; 37(3):864-6. PubMed ID: 9986878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.
    Pelletier R; Peter J; Antin C; Gonzalez C; Wood L; Walsh TJ
    J Clin Microbiol; 2000 Apr; 38(4):1563-8. PubMed ID: 10747144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
    Cartledge JD; Midgley J; Gazzard BG
    AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
    Metzger S; Hofmann H
    Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
    Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
    J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model.
    Valentin A; Le Guennec R; Rodriguez E; Reynes J; Mallie M; Bastide JM
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1342-5. PubMed ID: 8725998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review.
    White A; Goetz MB
    Clin Infect Dis; 1994 Oct; 19(4):687-92. PubMed ID: 7803633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
    Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
    Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
    Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
    Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans].
    Zhang X; Liu ZH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):279-84. PubMed ID: 27116986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.
    Ruhnke M; Eigler A; Tennagen I; Geiseler B; Engelmann E; Trautmann M
    J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus.
    He X; Tiballi RN; Zarins LT; Bradley SF; Sangeorzan JA; Kauffman CA
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2495-7. PubMed ID: 7840596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
    Tebbe B; Boyvat A; Geilen CC; Wölfer LU; Seibold M; Orfanos CE
    Hautarzt; 1996 Feb; 47(2):136-9. PubMed ID: 8868459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients.
    Menon T; Umamaheswari K; Kumarasamy N; Solomon S; Thyagarajan SP
    Acta Trop; 2001 Oct; 80(2):151-4. PubMed ID: 11600094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.
    Mann PA; McNicholas PM; Chau AS; Patel R; Mendrick C; Ullmann AJ; Cornely OA; Patino H; Black TA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5026-34. PubMed ID: 19786600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.